Skip to main content
Caplight Logo









Origin Genomics

Origin Genomics

Private
New York City, New YorkHealthcare & Life Scienceshttps://origingenomics.com/

Company Overview

Origin Genomics is a biotechnology company that develops precision germline gene correction technologies to address severe inherited diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

germline gene correctiongene editingmitochondrial replacement therapyMRTprecision medicineinherited diseasegenetic engineeringdesigner babiesgenomicsbiotechnologybioinformaticsrare disease treatmentreproductive medicinegene therapyembryology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Origin Genomics Comparables

Compare Origin Genomics with similar companies based on industry and business-model similarity.

Origin Genomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Preventive
90%
Tessera Therapeutics
58%
Beam Therapeutics
54%
View all Comparables

Origin Genomics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Cathy Tie

CEO and Founder

Founding Team

Origin Genomics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Origin Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Origin Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range1
Year Founded2026
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?